ODDITY Tech saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, rising from 79 to 82.
Hone Your Stock-Picking Skills By Focusing On These Factors
IBD's proprietary RS Rating tracks market leadership by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains often have an RS Rating north of 80 as they begin their biggest climbs.
ODDITY Tech is now considered extended and out of buy range after clearing a 51.00 buy point in a first-stage consolidation. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
The company showed 12% earnings growth in the latest quarterly report, while sales growth came in at 25%.
ODDITY Tech earns the No. 1 rank among its peers in the Cosmetics/Personal Care industry group. e.l.f. Beauty and Nu Skin Enterprises Cl A are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
